← Back to guidelines
Pediatrics3 papers

Galloway Mowat syndrome

Last edited: 4/15/2026

Overview

Galloway-Mowat syndrome (GMS) is an autosomal recessive disorder characterized by intrauterine growth retardation, central nervous system anomalies (including microcephaly and brain malformations), and early-onset nephrotic syndrome 13.

Diagnosis

  • Key Diagnostic Criteria:
  • - Marked intrauterine growth retardation - Central nervous system anomalies (microcephaly, porencephaly, encephalomalacia, developmental delay) - Early-onset nephrotic syndrome (often minimal change nephropathy) - Minor facial anomalies and contractural arachnodactyly may be present
  • Recommended Tests:
  • - Prenatal ultrasound for detecting growth restriction and microcephaly (potentially late-onset) - Postnatal renal biopsy to confirm glomerulopathy 13 - Thyroid function tests to screen for congenital hypothyroidism 2

    Management

  • First-Line Treatments:
  • - Management of nephrotic syndrome with corticosteroids (specific dosing not provided) 3
  • Adjunctive Treatments:
  • - Supportive care for developmental delays and seizures (specific treatments not detailed) - Thyroid hormone replacement for congenital hypothyroidism 2

    Special Populations

  • Pregnancy:
  • - Antenatal diagnosis possible through serial ultrasounds detecting late-onset intrauterine growth restriction 1
  • Pediatrics:
  • - Early onset of symptoms necessitates close monitoring and multidisciplinary care 13

    Key Recommendations

  • Antenatal surveillance with serial ultrasounds may aid in late-detected intrauterine growth restriction in pregnancies at risk for GMS (Evidence: Moderate 1)
  • Postnatal renal biopsy is essential for confirming the characteristic glomerulopathy in diagnosing GMS (Evidence: Moderate 3)
  • Early initiation of corticosteroid therapy for managing nephrotic syndrome is recommended, though specific dosing should be individualized (Evidence: Weak 3)
  • Comprehensive developmental support and monitoring are crucial for pediatric patients due to the severe neurological involvement (Evidence: Expert opinion)
  • References

    1 Kang L, Kuo PL, Lee KH, Liu YC, Chang CH, Chang FM et al.. Late-onset growth restriction in Galloway-Mowat syndrome: a case report. Prenatal diagnosis 2005. link 2 Hou JW, Wang TR. Galloway-Mowat syndrome in Taiwan. American journal of medical genetics 1995. link 3 Cooperstone BG, Friedman A, Kaplan BS. Galloway-Mowat syndrome of abnormal gyral patterns and glomerulopathy. American journal of medical genetics 1993. link

    Original source

    1. [1]
      Late-onset growth restriction in Galloway-Mowat syndrome: a case report.Kang L, Kuo PL, Lee KH, Liu YC, Chang CH, Chang FM et al. Prenatal diagnosis (2005)
    2. [2]
      Galloway-Mowat syndrome in Taiwan.Hou JW, Wang TR American journal of medical genetics (1995)
    3. [3]
      Galloway-Mowat syndrome of abnormal gyral patterns and glomerulopathy.Cooperstone BG, Friedman A, Kaplan BS American journal of medical genetics (1993)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG